Sirolimus (SIR) is a potent immunosuppressive agent with multiple proprieties. We report beneficial antiviral effects of SIR in an HIV-positive kidney transplant recipient who experienced low-level HIV-1 replication. The immunosuppressive agent was well tolerated by the patient, and no side effects were reported during follow-up. Despite immunosuppressive monotherapy, SIR ensured stable graft function.
Antiviral activity of sirolimus in an HIV-positive kidney transplant recipient / Alfano, G.; Fontana, F.; Mori, G.; Vicari, Emanuela; Dolci, G.; Franceschini, E.; Guaraldi, G.; Mussini, C.; Cappelli, G.. - In: INTERNATIONAL JOURNAL OF STD & AIDS. - ISSN 0956-4624. - 30:9(2019), pp. 919-922. [10.1177/0956462419839520]
Antiviral activity of sirolimus in an HIV-positive kidney transplant recipient
Alfano G.;Fontana F.;Mori G.;VICARI, EMANUELA;Dolci G.;Franceschini E.;Guaraldi G.;Mussini C.;Cappelli G.
2019
Abstract
Sirolimus (SIR) is a potent immunosuppressive agent with multiple proprieties. We report beneficial antiviral effects of SIR in an HIV-positive kidney transplant recipient who experienced low-level HIV-1 replication. The immunosuppressive agent was well tolerated by the patient, and no side effects were reported during follow-up. Despite immunosuppressive monotherapy, SIR ensured stable graft function.
| File | Dimensione | Formato | |
|---|---|---|---|
|
alfano2019.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
349.66 kB
Formato
Adobe PDF
|
349.66 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
